Expert panel asks drug cos to submit subgroup data on Molnupiravir
Antiviral medication molnupiravir, which could be a game-changer in ending the pandemic, is just one step away from getting approval in India. In a meeting held on Thursday the companies were asked to submit subgroup data stating how the drug has worked in people with health conditions like diabetes. People in the know told ET…Continue Reading









